Global Peptide Therapeutics Market Growth, Analysis, Key Players, Outlook, Report, Forecast 2023-2028

The ‘Global Peptide Therapeutics Market Price, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global peptide therapeutics market, assessing the market on the basis of its segments like marketing type, application, route of administration, and major regions.

Peptide therapeutics Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2018-2028)

• Forecast CAGR (2023-2028): 7.6%

Rising investments on research and development of peptide therapeutics is contributing to the robust growth of the global peptide therapeutics market. The rising prevalence of chronic conditions like cancer and tuberculosis and the growing expenditure on the healthcare sector are the major factors driving this market. The prevailing metabolic diseases like obesity and diabetes due to the adoption of unhealthy and sedentary lifestyles has surged the demand for peptide therapeutics. With the rising cases of cancer and growing awareness regarding the ill-effects of radiation therapy and chemotherapies, the demand for reliable peptide therapeutic drugs has increased, which is significantly contributing to the growth of the peptide therapeutics market.

Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/peptide-therapeutics-market/requestsample

The generic type of peptide therapeutics are likely to witness a robust growth in the forecast period due to the increased expenditure by the governments of various countries on healthcare and the fairly lower costs of generics. The parenteral route of administration segment is increasingly being preferred by a sizeable population owing to its significant benefits like improved biodiversity, faster delivery of drugs and ease of use. Due to the rise in the purchasing power of the population, the oral peptide therapeutics market is likely to face a surging demand. The spread of viral infections due to seasonal changes and reduced immunity has compelled the demand for peptide therapeutics.

Peptide therapeutics Industry Definition and Major Segments

Peptide therapeutics are a class of pharmaceutical agents, composed of chains of amino acids, that are used for the treatment of various diseases. They mimic the actions of peptides that are naturally occurring in the human body and are often used as ion channel ligands, hormones growth factors, anti-infective agents, and neurotransmitters. Peptide therapeutics have several advantages like low toxicity, easy synthesis, and high target selectivity.

On the basis of marketing type, the market is bifurcated into:

• Generic
• Branded

Based on application, the market is classified into:

• Gastrointestinal Disorders
• Neurological Disorders
• Metabolic Disorders
• Cancer
• Cardiovascular
• Others

On the basis of route of administration, the market is segmented into:

• Parenteral
• Oral
• Others

Based on region, the market is divided into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Peptide therapeutics Market Trends

The rising geriatric population and prevailing associated health problems offer a number of opportunities for the peptide therapeutics market. The increased collaborations of market players and the growing adoption of synthetic peptide drugs around the world are the major key trends of this market. The use of several peptide conjugates accelerates the healing process and boosts hormone levels, which is likely to increase the demand for peptide therapeutic treatments. The cost-effectiveness of peptide therapeutic drugs and the rising number of people affected from cardiovascular and gastrointestinal diseases have made peptide treatments a preferable choice for a sizeable population.

The emerging appeal for aesthetic and rising consciousness for promoting healthy skin amongst the growing population is likely to fuel to the demand for peptides, as they are used in cosmeceutical surgeries. This, coupled with the emerging trend for personalised therapeutical treatments, is likely to expand the peptide therapeutics market. The greater adoption of solid phase peptide synthesis (SPPS) due to scalability, improved control over physiochemical properties, and the growing demand for pore peptides, is expected to create a boom in this market. Enhanced manufacturing processes, analysis technology, and the use of bioinformatics to search for potential peptide drug candidates is further adding to the growth of the market for peptide therapeutics.

Key Market Players

The major players in the global peptide therapeutics market report are Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, and Amgen Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.